Patient Education Sheet Library
Search Results
Loncastuximab Tesirine
Loncastuximab terisine is used for large B-cell lymphoma (LBCL).
Treatment Given by InfusionDownloads:
Download (English)Epcoritamab and GemOx
Epcoritamab and GemOx (gemcitabine and oxaliplatin) is used for diffuse large B-cell lymphoma (DLBCL).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Glofitamab and GemOx
Glofitamab and GemOx (gemcitabine and oxaliplatin) is used for diffuse large B-cell lymphoma (DLBCL).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Rituximab, Cyclophosphamide, Vincristine and Prednisone
The combination of rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP) is used for Non-Hodgkin lymphoma (NHL).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Doxorubicin, Vinblastine and Dacarbazine
The combination of doxorubicin, vinblastine, and dacarbazine (AVD) is used for Hodgkin lymphoma (HL).
Treatment Given by InfusionDownloads:
Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine and Dexamethasone
The combination of brentuximab vedotin, etoposide, cyclophosphamide, doxorubicin, dacarbazine, and dexamethasone (BrECADD) is used for…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Cladribine and Rituximab
Cladribine and rituximab is used for hairy cell leukemia (HCL).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Liposomal Irinotecan, Leucovorin, Fluorouracil and Oxaliplatin
The combination of liposomal irinotecan, leucovorin, fluorouracil (5-FU), and oxaliplatin (NALIRIFOX) is used for pancreatic…
Treatment Given by InfusionDownloads:
Liposomal Irinotecan, Fluorouracil and Leucovorin
The combination of liposomal irinotecan, fluorouracil (5-FU), and leucovorin is used for pancreatic cancer.
Treatment Given by InfusionDownloads:
Pembrolizumab and GVD
The combination of pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) is used for Hodgkin…
Treatment Given by InfusionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
